Trabeculectomy With MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors

September 24, 2017 updated by: Maha omar mahmoud said, Assiut University
  1. determine whether cataract surgery has a major effect on outcomes of trabeculectomy with MMC or not.
  2. Success rates of trabeculectomy with MMC in Queen Elizabeth hospital.
  3. recurrence rate of uveitis after glaucoma surgery

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

  1. determine different success rates of trabeculectomy with MMC undergone in QE hospital, UK.
  2. determine different complications and effect of cataract surgery on the outcome of glaucoma surgery

Study Type

Observational

Enrollment (Anticipated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Assiut
      • Egypt, Assiut, Egypt
        • Maha Said

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

cohort of patient documented on the database system of Queen Elizabeth hospital

Description

Inclusion Criteria:

  • Fesh trabeculectomy surgeries

Exclusion Criteria:

  • recurrent surgeries

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
uveitic/ POAG
Outcomes, success rates, complications of trabeculectomy with MMC in Uveitic glaucoma
Procedure: Trabeculectomy with MMC
glaucoma surgeries
Other Names:
  • I-STENT
POAG
Outcomes, success rates, complications of trabeculectomy with MMC and I stent in this groups
Procedure: Trabeculectomy with MMC
glaucoma surgeries
Other Names:
  • I-STENT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success rates
Time Frame: 5 year period
IOP less 21 mmHg
5 year period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Collaborators

The Queen Elizabeth Hospital

Investigators

  • Study Director: Dr Kamel Soliman, professor, Assiut University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2017

Primary Completion (Anticipated)

October 29, 2018

Study Completion (Anticipated)

December 29, 2018

Study Registration Dates

First Submitted

September 20, 2017

First Submitted That Met QC Criteria

September 24, 2017

First Posted (Actual)

September 26, 2017

Study Record Updates

Last Update Posted (Actual)

September 26, 2017

Last Update Submitted That Met QC Criteria

September 24, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1111 (Other Grant/Funding Number: Prima Psychiatry internal research fund)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

undecided yet

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe